Aerpio Pharmaceuticals, Inc.
HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta)
Last updated:
Abstract:
The disclosure provides compositions and methods for the treatment of ocular conditions associated with angiogenesis comprising administering an antibody that targets a tyrosine phosphatase inhibitor in a subject.
Status:
Application
Type:
Utility
Filling date:
17 Apr 2020
Issue date:
27 Aug 2020